{"id":"https://openalex.org/W4362623638","doi":"https://doi.org/10.1158/1535-7163.22508338.v1","title":"Supplementary Information and Data from The Combination of Vemurafenib and Procaspase-3 Activation Is Synergistic in Mutant BRAF Melanomas","display_name":"Supplementary Information and Data from The Combination of Vemurafenib and Procaspase-3 Activation Is Synergistic in Mutant BRAF Melanomas","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362623638","doi":"https://doi.org/10.1158/1535-7163.22508338.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22508338.v1","doi":"https://doi.org/10.1158/1535-7163.22508338.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22508338.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.22508338.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038891328","display_name":"Jessie Peh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405271866","display_name":"Carl R. Woese Institute for Genomic Biology","ror":"https://ror.org/036j6yj81","country_code":"US","type":"facility","lineage":["https://openalex.org/I4405271866"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessie Peh","raw_affiliation_strings":["Department of Chemistry,","Institute for Genomic Biology,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry,","institution_ids":[]},{"raw_affiliation_string":"Institute for Genomic Biology,","institution_ids":["https://openalex.org/I4405271866"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012219010","display_name":"Timothy M. Fan","orcid":"https://orcid.org/0000-0003-2510-7050","observed_orcids":["https://orcid.org/0000-0003-2510-7050"]},"institutions":[{"id":"https://openalex.org/I4405271866","display_name":"Carl R. Woese Institute for Genomic Biology","ror":"https://ror.org/036j6yj81","country_code":"US","type":"facility","lineage":["https://openalex.org/I4405271866"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy M. Fan","raw_affiliation_strings":["Department of Chemistry,","Department of Veterinary Clinical Medicine,","Institute for Genomic Biology,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry,","institution_ids":[]},{"raw_affiliation_string":"Department of Veterinary Clinical Medicine,","institution_ids":[]},{"raw_affiliation_string":"Institute for Genomic Biology,","institution_ids":["https://openalex.org/I4405271866"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050890809","display_name":"Kathryn L. Wycislo","orcid":"https://orcid.org/0000-0002-3074-6044","observed_orcids":["https://orcid.org/0000-0002-3074-6044"]},"institutions":[{"id":"https://openalex.org/I157725225","display_name":"University of Illinois Urbana-Champaign","ror":"https://ror.org/047426m28","country_code":"US","type":"education","lineage":["https://openalex.org/I157725225"]},{"id":"https://openalex.org/I4405271866","display_name":"Carl R. Woese Institute for Genomic Biology","ror":"https://ror.org/036j6yj81","country_code":"US","type":"facility","lineage":["https://openalex.org/I4405271866"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathryn L. Wycislo","raw_affiliation_strings":["Department of Chemistry,","Department of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA","Institute for Genomic Biology,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry,","institution_ids":[]},{"raw_affiliation_string":"Department of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA","institution_ids":["https://openalex.org/I157725225"]},{"raw_affiliation_string":"Institute for Genomic Biology,","institution_ids":["https://openalex.org/I4405271866"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113786729","display_name":"Howard S. Roth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405271866","display_name":"Carl R. Woese Institute for Genomic Biology","ror":"https://ror.org/036j6yj81","country_code":"US","type":"facility","lineage":["https://openalex.org/I4405271866"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard S. Roth","raw_affiliation_strings":["Department of Chemistry,","Institute for Genomic Biology,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry,","institution_ids":[]},{"raw_affiliation_string":"Institute for Genomic Biology,","institution_ids":["https://openalex.org/I4405271866"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027996458","display_name":"Paul J. Hergenrother","orcid":"https://orcid.org/0000-0001-9018-3581","observed_orcids":["https://orcid.org/0000-0001-9018-3581"]},"institutions":[{"id":"https://openalex.org/I4405271866","display_name":"Carl R. Woese Institute for Genomic Biology","ror":"https://ror.org/036j6yj81","country_code":"US","type":"facility","lineage":["https://openalex.org/I4405271866"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul J. Hergenrother","raw_affiliation_strings":["Department of Chemistry,","Institute for Genomic Biology,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry,","institution_ids":[]},{"raw_affiliation_string":"Institute for Genomic Biology,","institution_ids":["https://openalex.org/I4405271866"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":1.0},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6809999942779541},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.621999979019165},{"id":"https://openalex.org/keywords/cell-line-authentication","display_name":"cell line authentication","score":0.7590000033378601},{"id":"https://openalex.org/keywords/mycoplasma-testing","display_name":"mycoplasma testing","score":0.9919999837875366}],"concepts":[{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.6805436611175537},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.5550028085708618},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.4883520305156708},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4121031165122986},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.39017897844314575},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.3875468373298645},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.34310978651046753},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.264771431684494},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.18973445892333984},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.1565607190132141},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09292066097259521},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.07314848899841309}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.22508338.v1","doi":"https://doi.org/10.1158/1535-7163.22508338.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22508338.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22508338","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Information_and_Data_from_The_Combination_of_Vemurafenib_and_Procaspase-3_Activation_Is_Synergistic_in_Mutant_BRAF_Melanomas/22508338","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22508338.v1","doi":"https://doi.org/10.1158/1535-7163.22508338.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22508338.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4392688561","https://openalex.org/W2428867055","https://openalex.org/W4362550717","https://openalex.org/W4361950217","https://openalex.org/W2041052361","https://openalex.org/W2505591268"],"abstract_inverted_index":{"The":[0],"supplementary":[1,12,15],"information":[2],"file":[3],"contains":[4],"details":[5],"about":[6],"primers":[7],"used":[8],"for":[9],"this":[10],"work,":[11],"Figures":[13],"S1-S8,":[14],"Table":[16],"S1,":[17],"and":[18,24],"results":[19],"from":[20,25],"cell":[21],"line":[22],"authentication":[23],"mycoplasma":[26],"testing.":[27]},"counts_by_year":[],"updated_date":"2026-09-04T10:56:28.161419","created_date":"2023-04-07T00:00:00"}